Rodman & Renshaw Archives - Page 12 of 44

MondayNov 03, 2008 6:19 am

Emisphere Technologies, Inc. (NASDAQ: EMIS)

Emisphere Technologies, Inc. (NASDAQ: EMIS), a biopharmaceutical company, is focused on utilizing its Eligen(r) Technology to uniquely deliver therapeutic molecules. Traditionally, these molecules are delivered by injection, and in many cases, are limited because of poor bioavailability, slow on-set of action or variable absorption. With Eligen(r) Technology, oral administration is possible as well other delivery pathways. For further information, visit the Company's web site at www.emisphere.com.

MondayNov 03, 2008 6:19 am

TUSK Energy Corporation (TSX: TSK CN)

TUSK Energy Corporation (TSX: TSK CN) is focused on the acquisition, exploration, development and production of oil and natural gas reserves in three focus areas in the northwestern part of the Western Canadian Sedimentary Basin. The company is currently developing natural gas in the Conroy area of northeastern British Columbia and light oil and natural gas in the Peace River Arch and Mega/Gutah areas of northern Alberta. For further information, visit the Company's web site at www.tusk-energy.com.

MondayNov 03, 2008 6:19 am

Trubion Pharmaceuticals, Inc. (NASDAQ: TRBN)

Trubion Pharmaceuticals, Inc. (NASDAQ: TRBN), a biopharmaceutical company, focuses its efforts on creating a pipeline of innovative protein therapeutic product candidates designed to treat autoimmune and inflammatory diseases and cancer. The company aims to develop an assortment of first-in-class and best-in-class products, customized for optimal safety, efficacy, and convenience. Trubion’s product development efforts are focused on three technology pillars that encompass the expanded foundation for Trubion product development. For further information, visit the Company's web site at www.trubion.com.

MondayNov 03, 2008 6:18 am

Emergent BioSolutions, Inc. (NYSE: EBS)

Emergent BioSolutions, Inc. (NYSE: EBS), a leading biopharmaceutical company, is focused on its mission to protect life. To achieve this goal, the company develops, manufactures, and commercializes immune related biologics, vaccines and biotherapeutics designed to support the body’s immune system to prevent or treat infectious and other life threatening diseases. Their broad product pipeline also includes: two “next generation” anthrax vaccines, two anthrax therapeutics (immunoglobulin and monoclonal), two botulinum vaccines and a botulinum therapeutic, an oral typhoid vaccine, a next generation tuberculosis vaccine, a hepatitis B immunotherapy, and a chlamydia vaccine. For further information, visit the Company's web site at…

MondayNov 03, 2008 6:18 am

Transgenomic, Inc. (OTC BB: TBIO)

Transgenomic, Inc. (OTC BB: TBIO), a global biotechnology company, is focused on providing novel products and services for automated high sensitivity genetic variation and mutation analysis. The company’s offerings currently include systems, products, discovery and laboratory testing services that find application in the academic and medical research, clinical laboratory and pharmaceutical markets in the fields of pharmacogenomics and personalized medicine. For further information, visit the Company's web site at www.transgenomic.com.

MondayNov 03, 2008 6:18 am

eFuture Information Technology, Inc. (NASDAQ:EFUT)

eFuture Information Technology, Inc. (NASDAQ: EFUT) is focused on applying advanced technology, valuable professional service and best practices to help clients purge inefficiencies and ineffectiveness in business. The company’s clients are centered in the retail, automotive, general household appliance and consumer goods industries. e-Future currently provides software products and services to more than 800 clients. For further information, visit the Company's web site at www.e-future.com.cn.

MondayNov 03, 2008 6:17 am

Transdel Pharmaceuticals, Inc. (OTC BB: TDLP)

Transdel Pharmaceuticals, Inc. (OTC BB: TDLP), a specialty pharmaceutical company, is dedicated to developing and commercializing non-invasive topically delivered medications. Ketotransdel, Transdel’s lead topical drug, leverages the company’s proprietary Transdel™ cream formulation to facilitate the passage of ketoprofen through the skin to reach underlying tissue where the drug exerts its prolonged localized anti-inflammatory and analgesic effect. For further information, visit the Company's web site at www.transdelpharma.com.

MondayNov 03, 2008 6:17 am

ECU Silver Mining, Inc. (TSX: (OTC BB: ECU CN)

ECU Silver Mining, Inc. (TSX: ECU CN), a Canadian-based, mid-tier, producing mining company, has been focused on the engagement of gold, silver, lead and zinc exploration and exploitation since 1997. The Company has a cluster of seven mines in the historically prolific Velardeña mining district, Central Mexico, where it has had a number of major discoveries. ECU processes ore at its wholly owned milling facilities. For further information, visit the Company's web site at www.ecu.ca.

MondayNov 03, 2008 6:17 am

Trans-Orient Petroleum Ltd. (OTC BB: TOPLF)

Trans-Orient Petroleum Ltd. (OTC BB: TOPLF) is focused on leveraging advanced drilling and multi-fracturing technology to unlock the potentially vast oil and gas resource contained in world-class source rocks. The company has multi-million acre permits in New Zealand's East Coast Basin. This basin is an exploration frontier renowned for fractured reservoir potential, and Trans-Orient is at the forefront of this opportunity. For further information, visit the Company's web site at www.transorient.com.

MondayNov 03, 2008 6:16 am

Trans Energy, Inc. (OTC BB: TENG)

Trans Energy, Inc. (OTC BB: TENG), an independent exploration and production company, is focused on exploring, developing and producing oil and natural gas in the Appalachian Basin. The company, operating since 1994, restructured itself during 2006 with a new management team, a focus on oil and gas development, and a business plan for rapid growth. Chief Operating Officer and Director of the Company William F. Woodburn has more than three decades of experience in the oil and gas industry. For further information, visit the Company's web site at www.transenergyinc.com.

Site Search

Company Search

Tag: Rodman & Renshaw

Emisphere Technologies, Inc. (NASDAQ: EMIS)

TUSK Energy Corporation (TSX: TSK CN)

Trubion Pharmaceuticals, Inc. (NASDAQ: TRBN)

Emergent BioSolutions, Inc. (NYSE: EBS)

Transgenomic, Inc. (OTC BB: TBIO)

eFuture Information Technology, Inc. (NASDAQ:EFUT)

Transdel Pharmaceuticals, Inc. (OTC BB: TDLP)

ECU Silver Mining, Inc. (TSX: (OTC BB: ECU CN)

Trans-Orient Petroleum Ltd. (OTC BB: TOPLF)

Trans Energy, Inc. (OTC BB: TENG)

Market Basics

Newsletter Publishers

Public Companies